omeprazole has been researched along with Blood Poisoning in 5 studies
Omeprazole: A 4-methoxy-3,5-dimethylpyridyl, 5-methoxybenzimidazole derivative of timoprazole that is used in the therapy of STOMACH ULCERS and ZOLLINGER-ELLISON SYNDROME. The drug inhibits an H(+)-K(+)-EXCHANGING ATPASE which is found in GASTRIC PARIETAL CELLS.
omeprazole : A racemate comprising equimolar amounts of (R)- and (S)-omeprazole.
5-methoxy-2-{[(4-methoxy-3,5-dimethylpyridin-2-yl)methyl]sulfinyl}-1H-benzimidazole : A member of the class of benzimidazoles that is 1H-benzimidazole which is substituted by a [4-methoxy-3,5-dimethylpyridin-2-yl)methyl]sulfinyl group at position 2 and a methoxy group at position 5.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Omeprazole (OMZ) is a proton pump inhibitor that is used to reduce gastric acid secretion, but little is known about its possible liver protective effects." | 5.72 | Omeprazole Increases Survival Through the Inhibition of Inflammatory Mediaters in Two Rat Sepsis Models. ( Hashimoto, Y; Hatta, M; Kaibori, M; Kotsuka, M; Nakatake, R; Nishizawa, M; Okumura, T; Okuyama, T; Sekimoto, M; Yoshida, T, 2022) |
| "Omeprazole (OMZ) is a proton pump inhibitor that is used to reduce gastric acid secretion, but little is known about its possible liver protective effects." | 1.72 | Omeprazole Increases Survival Through the Inhibition of Inflammatory Mediaters in Two Rat Sepsis Models. ( Hashimoto, Y; Hatta, M; Kaibori, M; Kotsuka, M; Nakatake, R; Nishizawa, M; Okumura, T; Okuyama, T; Sekimoto, M; Yoshida, T, 2022) |
| "Especially patients with severe sepsis or septic shock are prone to develop lesions of the upper gastrointestinal tract with consecutive bleeding." | 1.35 | [Stress ulcer prophylaxis in septic patients. Evidence-based overview]. ( Elke, G; Schädler, D; Scholz, J; Weiler, N; Zick, G, 2008) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (40.00) | 29.6817 |
| 2010's | 2 (40.00) | 24.3611 |
| 2020's | 1 (20.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kotsuka, M | 1 |
| Hashimoto, Y | 1 |
| Nakatake, R | 1 |
| Okuyama, T | 1 |
| Hatta, M | 1 |
| Yoshida, T | 1 |
| Okumura, T | 1 |
| Nishizawa, M | 1 |
| Kaibori, M | 1 |
| Sekimoto, M | 1 |
| Roa Colomo, A | 1 |
| García Robles, A | 1 |
| Ruiz Escolano, E | 1 |
| Furr, M | 1 |
| Cohen, ND | 1 |
| Axon, JE | 1 |
| Sanchez, LC | 1 |
| Pantaleon, L | 1 |
| Haggett, E | 1 |
| Campbell, R | 1 |
| Tennent-Brown, B | 1 |
| Yarze, JC | 1 |
| Elke, G | 1 |
| Schädler, D | 1 |
| Zick, G | 1 |
| Scholz, J | 1 |
| Weiler, N | 1 |
5 other studies available for omeprazole and Blood Poisoning
| Article | Year |
|---|---|
Omeprazole Increases Survival Through the Inhibition of Inflammatory Mediaters in Two Rat Sepsis Models.
Topics: Animals; Cell Culture Techniques; Disease Models, Animal; Galactosamine; Hepatectomy; Hepatocytes; I | 2022 |
Black esophagus, is it as bad as it seems?
Topics: Alcoholism; Colonic Pseudo-Obstruction; Esophagitis; Esophagoscopy; Food, Formulated; Gastrointestin | 2019 |
Treatment with histamine-type 2 receptor antagonists and omeprazole increase the risk of diarrhoea in neonatal foals treated in intensive care units.
Topics: Animals; Animals, Newborn; Anti-Ulcer Agents; Clostridium Infections; Diarrhea; Female; Histamine H2 | 2012 |
Septic complications after variceal cyanoacrylate injection.
Topics: Anti-Ulcer Agents; Cyanoacrylates; Esophageal and Gastric Varices; Hemostasis, Endoscopic; Humans; O | 2005 |
[Stress ulcer prophylaxis in septic patients. Evidence-based overview].
Topics: Anti-Ulcer Agents; Cimetidine; Duodenal Ulcer; Evidence-Based Medicine; Gastric Acid; Gastrointestin | 2008 |